DNA damage response defect in Williams-Beuren syndrome

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Williams-Beuren syndrome (WBS) is a genetic disorder caused by a chromosome 7q11.23 microdeletion, associated with cardiovascular issues, intellectual disability, and distinct facial features.
• Recent findings suggest a potential predisposition to non-Hodgkin's lymphoma in WBS patients, prompting investigation into underlying genetic mechanisms.
• Three genes (RFC2, GTF2I, BAZ1B) hemizygously deleted in WBS are implicated in DNA damage response pathways.

Purpose of the Study:

• To investigate the role of RFC2, GTF2I, and BAZ1B genes in DNA damage response pathways in WBS.
• To determine if WBS-associated gene deletions impact cellular responses to genotoxic stress.
• To explore the link between WBS, DNA damage response, and potential cancer predisposition.

Main Methods:

• Primary fibroblasts from WBS patients and 293T cells with siRNA-mediated gene depletion were used.
• Cell proliferation, cell cycle, γ-H2.A.X induction, and DNA damage response protein expression were analyzed.
• Cells were exposed to genotoxic agents like hydroxyurea to assess DNA damage response.

Main Results:

• WBS patient-derived cells exhibited impaired hydroxyurea-induced phosphorylation of CHK1, indicating a defective ATR-dependent DNA damage response.
• Despite the impaired response, WBS cells did not show increased sensitivity to genotoxic agents.
• Depletion of RFC2, GTF2I, or BAZ1B in 293T cells did not significantly alter DNA damage response.

Conclusions:

• The ATR-dependent DNA damage response pathway is impaired in cells from Williams-Beuren syndrome patients.
• This impairment in DNA damage response is dispensable for cell viability under genotoxic stress.
• Further research is needed to elucidate the precise mechanism of ATR pathway impairment in WBS.